M&A Deal Summary |
|
|---|---|
| Date | 2019-12-18 |
| Target | WraSer Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | Legacy-Xspire |
| Deal Type | Merger |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2019 |
| Sector | Life Science |
Legacy-Xspire market and distribute niche branded and generic prescription products to physicians, pharmacies, wholesale distributors, and specialty pharmaceutical distributors across the United States. Legacy-Xspire’s product portfolio consists primarily of therapies for pain management and steroid-responsive disease states. Legacy-Xspire is based in Ridgeland, Mississippi.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 4 |
| Sector: Life Science M&A | 3 of 4 |
| Type: Merger M&A Deals | 3 of 3 |
| State: Mississippi M&A | 3 of 3 |
| Country: United States M&A | 3 of 4 |
| Year: 2019 M&A | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-12-18 |
Xspire Pharma
Madison, Mississippi, United States Xspire Pharma LLC is a privately held, specialty pharmaceutical company prides itself on patient-centered, niche branded and generic pharmaceuticals that fill a void in the prescription market space. Xspire Pharma was established in 2011 and is based in Madison, Mississippi. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-09-03 |
New American Therapeutics - ZONTIVITY
Parsippany, New Jersey, United States ZONTIVITY is a prescription medicine used to treat people who have had a heart attack or reduced blood flow in their legs (peripheral artery disease). ZONTIVITY is used with aspirin and/or clopidogrel to lower your chance of having another serious problem with your heart or blood vessels, such as heart attack, stroke, or death. |
Buy | - |
